<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aims </plain></SENT>
<SENT sid="1" pm="."><plain>Nuclear translocation of β-catenin is common in many <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> including esophageal <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>As a mediator of Wnt signaling pathway, nuclear β-catenin can activate many growth-related genes including CCN1, which in turn can induce β-catenin translocation </plain></SENT>
<SENT sid="3" pm="."><plain>CCN1, a matricellular protein, signals through various integrin receptors in a cell-dependent manner to regulate cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, proliferation, and survival </plain></SENT>
<SENT sid="4" pm="."><plain>Its elevation has been reported in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e> as well as other esophageal abnormalities such as <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The aim of this study is to examine the relationship between CCN1 and β-catenin in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Methods and Results </plain></SENT>
<SENT sid="7" pm="."><plain>The expression and correlation between CCN1 and β-catenin in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e> tissue were examined through immunohistochemistry and further analyzed in both <z:mpath ids='MPATH_458'>normal</z:mpath> esophageal epithelial cells and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e> cells through microarray, functional blocking and in situ protein ligation </plain></SENT>
<SENT sid="8" pm="."><plain>We found that nuclear translocation of β-catenin in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e> cells required high level of CCN1 as knockdown of CCN1 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e> cells reduced β-catenin expression and translocation </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, we found that integrin α(11) was highly expressed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESCC</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue and functional blocking integrin α(11) diminished CCN1-induced β-catenin elevation and translocation </plain></SENT>
<SENT sid="10" pm="."><plain>Conclusions </plain></SENT>
<SENT sid="11" pm="."><plain>Integrin α(11) mediated the effect of CCN1 on β-catenin in esophageal epithelial cells </plain></SENT>
</text></document>